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Bisphenol A (BPA) is used extensively in 
industry and commerce to manufacture 
polycarbonate plastics (which can be used in 
baby bottles, water storage tanks, or supply 
pipes) and components of food packaging (for 
example, in the lining of food cans), among 
other applications (Vandenberg et al. 2009). 
BPA can leach from some of these polymers 
into water or food products. In a representa-
tive subset of participants of the 2003–2004 
National Health and Nutrition Examination 
Survey (NHANES), 92.6% of urinary samples 
presented detectable concentrations of BPA, 
indicating that exposure to BPA is common 
among the general population in the United 
States (Calafat et al. 2008).
BPA has been reported to have both estro-
genic and anti androgenic effects (Akingbemi 
et al. 2004; Lee et al. 2003; Wetherill et al. 
2007). Several toxicological studies (Richter 
et al. 2007) have pointed out that rodents 
exposed to BPA during the pre natal or peri-
natal period show a large variety of adverse 
reproductive outcomes, including decreased 
epididymal weight and daily sperm production 
(Salian et al. 2009a, 2009b; vom Saal et al. 
1998) and increased prostate weight (Nagel 
et al. 1997). Regarding pre pubertal or puber-
tal exposures, rodent studies have described 
a dramatic decrease in testosterone (T) levels 
(Herath et al. 2004; Takao et al. 1999) and 
epididymal sperm counts (Herath et al. 2004) 
after BPA exposure. Adult male mice showed a 
significant reduction in testicular sperm counts, 
as well as epididymal sperm counts, after expo-
sure to 25 or 100 ng/kg BPA (Al-Hiyasat et al. 
2002). Tohei et al. (2001) reported that plasma 
concentrations of T were decreased and plasma 
concentrations of luteinizing hormone (LH) 
were increased in BPA-treated male adult rats 
compared with control rats.
Studies have reported secular declining 
trends in T levels in humans (Andersson et al. 
2007; Travison et al. 2007) consistent with 
decreases in sperm concentration (Carlsen 
et al. 1992; Swan et al. 1997). It has been 
hypothesized that these changes might be the 
result, at least in part, of increasing human 
exposure to endocrine-disrupting compounds 
(EDCs) (Sharpe and Skakkebaek 2008). To 
our knowledge, only four studies have exam-
ined the relationship between reproductive 
function in men and BPA exposure. Takeuchi 
and Tsutsumi (2002) investigated the rela-
tionship between BPA exposure and hormone 
levels in men (n = 11) and women (n = 30), 
showing statistically significant positive cor-
relations between serum BPA concentrations 
and total and free testosterone (FT) levels in 
both sexes. Hanaoka et al. (2002) studied 
men occupationally exposed to BPA during 
the application of epoxy resins (n = 42) com-
pared with matched control workers without 
exposure (n = 42). Urinary concentrations 
of BPA were significantly higher in exposed 
workers, and the authors found a significant 
inverse association between urinary BPA 
concentrations and follicle-stimulating hor-
mone (FSH) levels after controlling for age 
and alcohol use. Li et al. (2010) reported that 
BPA-exposed workers (n = 164) had higher 
risk of male sexual dysfunction, including, 
for example, reduced sexual desire or erectile 
difficulty compared with unexposed workers 
(n = 386). Recently, Meeker et al. (2010), 
examining a male population attending a fer-
tility clinic (n = 167), reported inverse associa-
tions between urinary BPA concentrations and 
serum inhibin B levels and the estradiol (E2)/T 
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Background: Rodent and in vitro studies have demonstrated the estrogenicity of bisphenol A 
(BPA). However, few studies have examined the relationship between human exposure to BPA and 
male reproductive function.
oBjectives: We investigated the relationships between environmental BPA exposure and repro-
ductive parameters, including semen quality and male reproductive hormones, in prospectively 
recruited fertile men.
Methods: Participants (n = 375) were partners of pregnant women who participated in the Study 
for Future Families in four U.S. cities, and all of the men provided blood, semen, and urine samples. 
BPA was measured in urine. Serum samples were analyzed for reproductive hormones, including 
follicle-stimulating hormone, luteinizing hormone (LH), testosterone, inhibin B, estradiol, and 
sex hormone–binding globulin (SHBG), as well as the free androgen index (FAI). Semen analyses 
were performed according to World Health Organization criteria. Pearson correlations were used 
for unadjusted analyses, and multiple linear regression analyses were used to examine associations 
controlling for age, body mass index, smoking, ethnicity, urinary creatinine concentration, time of 
sample collection, and duration of abstinence.
results: After multivariate adjustment, we observed no significant associations between any semen 
parameter and urinary BPA concentration. However, a significant inverse association was found 
between urinary BPA concentration and FAI levels and the FAI/LH ratio, as well as a significant 
positive association between BPA and SHBG.
conclusions: Our results suggest that, in fertile men, exposure to low environmental levels of BPA 
may be associated with a modest reduction in markers of free testosterone, but any effects on repro-
ductive function are likely to be small, and of uncertain clinical significance.
key words: bisphenol A, endocrine disruptors, male hormones, semen quality, xenoestrogens. 
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ratio, and positive associations with serum 
FSH levels and the FSH/inhibin B ratio.
This is the first study to examine BPA and 
serum hormones in fertile men. It comple-
ments the earlier studies in occupational 
cohorts (with their higher exposure levels), 
and infertility clinic patients (enriched with 
men with altered hormone levels). Together 
with those previous studies, it is now possible 
to examine BPA across a range of exposures 
and reproductive potential.
The aim of the present study is to examine 
the associations between urinary BPA con-
centrations and reproductive function (semen 
quality and hormone levels) in a population 
of fertile men.
Materials and Methods
Study population. All men were participants 
in the Study for Future Families (SFF), a 
multi center study of pregnant women and 
their partners conducted at prenatal clinics 
affiliated with university hospitals in four 
U.S. cities (Harbor-UCLA and Cedars-
Sinai Medical Center in Los Angeles, CA; 
University of Minnesota Medical Center in 
Minneapolis, MN; University Physicians in 
Columbia, MO; and University of Iowa, Iowa 
City, IA) between 1999 and 2005. Methods 
for clinical examination, data collection, and 
semen analysis, which were standardized 
across centers, have been described previously 
(Swan et al. 2003). Couples were recruited 
at the prenatal clinic, and only those whose 
pregnancy was conceived without medical 
assistance were eligible. The men completed 
a questionnaire, received a physical exami-
nation, and gave blood, semen, and urine 
samples on the same day during the pre natal 
visit. Questions included demographics, 
recent fever, and history of sexually transmit-
ted diseases, as well as lifestyle factors (smok-
ing, and alcohol and caffeine consumption) 
and diet. Although 950 men participated in 
SFF, urine was not collected until the second 
year of the study, and approximately 85% of 
men provided a semen sample. This analysis is 
based on the 360 (39%) men for whom data 
on serum hormones and urinary BPA concen-
trations were available (n = 302 for complete 
covariates) and the 375 men with data on 
semen parameters and urinary BPA concen-
trations (n = 317 for complete covariates). 
The involvement of the Centers for Disease 
Control and Prevention (CDC) laboratory 
was limited and determined not to consti-
tute engagement in human subjects research. 
This study has complied with all applicable 
requirements of the U.S. regulations. Human 
subject approvals were obtained from institu-
tional review boards at all participating insti-
tutions. Participation of human subjects did 
not occur until after written informed consent 
was obtained.
Urinary BPA measurements. The urinary 
concentrations of BPA in 375 men were deter-
mined at the Division of Laboratory Sciences, 
National Center for Environmental Health, 
CDC, which had no access to participant data. 
Urine samples were dispensed into smaller 
aliquots and frozen within 1 hr of collection, 
stored at –20°C, then shipped on dry ice over-
night to the CDC, where they remained stored 
at or below –40°C until analysis. The total 
urinary concentration of BPA (free plus conju-
gated species) was meas ured using online sol-
id-phase extraction (SPE) coupled to isotope 
dilution–high-performance liquid chroma-
tography (HPLC)-tandem mass spectrometry 
(MS/MS) on a system constructed from sev-
eral HPLC Agilent 1100 modules (Agilent 
Technologies, Wilmington, DE, USA) cou-
pled to a triple quadrupole API 4000 mass 
spectrometer (Applied Biosystems, Foster City, 
CA, USA), as described in detail previously 
(Ye et al. 2005). Briefly, 100 µL urine was 
treated with β-glucuronidase/sulfatase (Helix 
pomatia, H1; Sigma Chemical Co., St. Louis, 
MO, USA) to hydrolyze the BPA-conjugated 
species. BPA was then retained and concen-
trated on a C18 reversed-phase size-exclusion 
SPE column (Merck KGaA, Darmstadt, 
Germany), separated from other urine matrix 
components using a pair of monolithic HPLC 
columns (Merck KGaA), and detected by 
negative ion-atmospheric pressure chemical 
ionization-MS/MS. The limit of detection 
(LOD) for BPA in a 0.1-mL urine sample was 
0.4 µg/L. Low-concentration (~ 4 µg/L) and 
high-concentration (~ 20 µg/L) quality control 
materials, prepared with pooled human urine, 
were analyzed with standard, reagent blank, 
and unknown samples (Ye et al. 2005).
Serum hormone analysis. Venous blood 
samples were drawn, and the serum was sepa-
rated and frozen at –80°C. All samples were 
analyzed for hormones in the same labo ra tory 
at the Rigshospitalet (Copenhagen, Denmark). 
Samples were shipped to Copenhagen on 
dry ice and stored at –20°C until hormone 
analysis was performed. The methods used 
have been described previously (Asklund 
et al. 2007; Bang et al. 2005). Briefly, hor-
mone assessments were done simultaneously 
to reduce intra laboratory variations. Serum 
levels of FSH, LH, and sex hormone–binding 
globulin (SHBG) were determined using time-
resolved immuno fluorometric assays (DELFIA; 
PerkinElmer, Skovlund, Denmark). Intra- and 
inter assay variations were both < 5% in each of 
the three assays. T levels were determined using 
a time-resolved fluoro immuno assay (DELFIA; 
PerkinElmer) with intra- and interassay varia-
tion < 8%. E2 was measured by radio immuno-
assay (Pantex, Santa Monica, CA, USA) with 
an intra assay variation of < 8% and an inter-
assay variation of < 13%. Inhibin B levels were 
determined by a specific two-sided enzyme 
immuno metric assay (Oxford Bio-Innovation 
Ltd, Bicester, UK) with intra- and inter assay 
variation of 13% and 18%, respectively. The 
free androgen index (FAI) was calculated as 
total T × 100/SHBG. The FT concentration 
was calculated using the equation of Vermeulen 
et al. (1999).
Semen collection and analysis. Men col-
lected semen samples by masturbation at the 
clinic, and almost all samples were processed 
within 45 min of collection. These methods 
are described in detail elsewhere (Brazil et al. 
2004). Briefly, ejaculate volumes were esti-
mated by specimen weight, assuming a semen 
density of 1.0 g/mL. Sperm concentration 
was evaluated by hemacytometer (Improved 
Neubauer; Hauser Scientific Inc., Horsham, 
PA, USA). In this analysis, the percent motile 
sperm refers to the percentage of sperm with 
any flagellar movement, whether twitching or 
progressive. Motility was also analyzed using 
the World Health Organization (WHO) 1999 
a, b, c, and d method, with forward motile 
sperm classified as a + b (WHO 1999). Seminal 
smears were prepared at the clini cal centers 
and shipped to the Andrology Coordinating 
Center at the University of California, Davis, 
California, for Papanicalou staining, analy-
sis, and storage. A single technician assessed 
sperm morphology using the strict morphol-
ogy method, as recom mended by the WHO 
(1999). In addition to the primary measures of 
semen quality (sperm concentration, volume, 
percent morphologically normal sperm, and 
percent motile sperm), we analyzed the total 
sperm count (volume × sperm concentration) 
and total motile count (volume × sperm con-
centration × motility). Men were requested 
to observe a 2- to 5-day abstinence period, 
and the importance of accurately reporting the 
actual abstinence period was stressed.
Statistical analyses. The frequency distri-
bution of serum hormones (except E2) and 
urinary BPA concentrations showed skewed 
(non-normal) distributions and were trans-
formed using the natural log (ln) before 
analysis. We used Pearson correlation coef-
ficients (R) and parametric tests to explore the 
relationship between each hormone level and 
urinary BPA concentration, both unadjusted 
and adjusted by urinary dilution (BPA con-
centration divided by creatinine concentra-
tion and expressed as micrograms per gram 
creatinine). Multiple linear regression analysis 
was then performed controlling for covari-
ates previously noted to be associated with 
male reproductive function. The following 
covariates were included in the final model 
for hormone analysis: age, age squared, body 
mass index (BMI), smoking status (current 
smoker vs. not current smoker), ethnicity 
[(African American vs. others) because of rele-
vance of racial and ethnic differences in sex 
steroids (Wang et al. 2007)], study center 
Mendiola et al.
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(Missouri vs. Iowa, Minnesota, or California; 
taking Missouri as a reference value because 
of lower semen quality compared with other 
centers), time of sample collection, and urinary 
creatinine concentration (ln-transformed). We 
adjusted for creatinine to account for urine 
dilution, because urine dilution can influence 
urinary BPA concentrations. For analyses of 
semen parameters, stressful life events (< 2 vs. 
≥ 2 events) (Gollenberg et al. 2010), ejacula-
tion abstinence time (hours), time from semen 
collection to initial processing (minutes), and 
time required to conduct semen analysis (min-
utes) were included in multivariate models. 
Ejaculation abstinence time is related to semi-
nal volume and sperm concentration but not 
with sperm motility or morphology. Time 
from semen collection to initial processing and 
time required to conduct semen analysis are 
related to sperm motility but have no relation-
ship with other sperm variables. Age, BMI, uri-
nary creatinine concentration (ln-transformed), 
time of sample collection, ejaculation absti-
nence time, time from semen collection to ini-
tial processing, and time required to conduct 
semen analysis were modeled as continuous 
independent variable and all others as dichoto-
mous variables. Most BPA concentrations were 
> LOD (89.7%); those < LOD were assigned a 
value of LOD divided by the square root of 2 
(Hornung and Reed 1990). The level of statis-
tical significance was set at 0.05. Data analysis 
was performed independently by two analysts, 
one using SAS version 9.1 (SAS Institute Inc., 
Cary, NC, USA) and one using SPSS version 
17.0 (SPSS Inc., Chicago, IL, USA).
Results
Mean age (± SD) and BMI (kilograms per 
meter squared; ± SD) of the included men 
were 31.9 ± 6.3 years (range, 18–53 years) 
and 28.3 ± 5.6 (range, 18.3–49.9), respec-
tively. Forty-one percent of these men were 
overweight (BMI of 25–30), and an addi-
tional 29% were obese (BMI ≥ 30). Twenty-
three percent of the men were smokers, 70% 
were white and 10% were African American. 
Table 1 shows the charac teristics of semen 
parameters for our study population. Summary 
statistics for men’s reproductive hormones and 
urinary BPA concentrations (before creatinine 
adjustment) are shown in Table 2. Almost 
90% (n = 235) of the urinary samples had 
concentrations of BPA > LOD (0.4 µg/L). The 
mean (± SD) urinary creatinine concentration 
was 144 ± 79.8 mg/dL (median, 138 mg/dL).
In unadjusted correlations, age was 
inversely correlated with T, FAI, and FT 
(R = −0.12, −0.32, −0.25, respectively; 
p < 0.05 for all) and positively correlated with 
FSH and SHBG (R = 0.13 and 0.15, respec-
tively; p < 0.05 for both). BMI was negatively 
correlated with T, inhibin B, SHBG, and FT 
(R = −0.44, −0.35, −0.48, −0.23, respectively; 
p < 0.01 for all) and positively correlated with 
E2 (R = 0.24, p < 0.01). We also saw a smaller 
(positive) correlation between BMI and FAI, 
but it was driven by a small number of indi-
viduals with high BMI and very low SHBG. 
Other than these individuals, FAI and FT 
were highly correlated (data available on 
request). Current smokers had higher mean 
E2 levels than non smokers (93.5 pg/mL vs. 
82.4 pg/mL, p ≤ 0.01).
Table 3 shows correlation coefficients for 
men’s reproductive hormones and urinary BPA 
concentrations (both unadjusted for creati-
nine and creatinine adjusted). These uni variate 
associations differed somewhat before and after 
creatinine adjustment. We observed significant 
inverse correlation between creatinine-adjusted 
urinary BPA concentrations and FAI level, 
FAI/LH ratio, and FT/LH ratio. All of these 
meas ures are related to available T or SHBG 
levels, but neither T nor SHBG were correlated 
with urinary BPA. We also found a suggestive 
inverse correlation between creatinine-adjusted 
BPA concentrations and FT (p = 0.08) and 
T/LH ratio (p = 0.054). Correlation coefficients 
between semen parameters and unadjusted and 
creatinine-adjusted BPA concentrations are 
shown in Table 4. Seminal volume was nega-
tively correlated with both unadjusted and 
creatinine-adjusted urinary BPA concentrations, 
but no other semen parameters were apprecia-
bly associated with BPA concentration.
Table 5 shows the results of the multi-
variate analysis for men’s reproductive hormone 
and urinary BPA concentrations. Consistent 
with the unadjusted results, we saw no signifi-
cant associations between BPA concentration 
and any of the six hormones. After adjustment 
for possible confounders, we observed signifi-
cant inverse associations between urinary BPA 
and both FAI and the FAI/LH ratio [regression 
coefficient (β) = −0.05; 95% confidence inter-
val (CI), −0.09 to −0.004; and β= −0.11; 95% 
CI, −0.18 to −0.03, respectively], although not 
for FT, a meas ure of free T calculated from 
concentrations of total T, albumin, and SHBG 
along with T-binding constants to albumin 
and SHBG. There was a significant positive 
association between serum SHBG levels and 
urinary BPA concentration (β = 0.07; 95% 
CI, 0.007–0.13). We also observed sugges-
tive inverse associations between urinary BPA 
concentration and both FT/LH ratio and 
seminal volume (Table 6), and a suggestive 
positive association between BPA concen-
trations and serum LH levels. We reran our 
statistical models excluding two outliers (sub-
jects with extremely high concentrations of 
urinary BPA) and observed somewhat weaker 
but still statistically significant associations 
(data not shown). An inter quartile increase in 
urinary BPA concentrations (2.1 µg/L) for a 
32-year-old non smoker with BMI of 28 kg/m2 
would be predicted to decrease FAI levels and 
FAI/LH ratio around 6% and 11%, respec-
tively. After adjustment, there were no sig-
nificant associations between urinary BPA 
concentrations and any of the semen param-
eters examined (Table 6).
Discussion
To our knowledge, this is the first study to 
examine the relationships between urinary BPA 
concentrations and markers of reproductive 
function (semen quality and hormone levels) 
in fertile men. We saw a significant association 
Table 1. Characteristics of semen parameters for 
our study population (n = 375).
Variable
Mean ± SD 
(median)
Seminal volume (mL) 3.9 ± 1.7
(3.6)
Sperm concentration (× 106/mL) 79.9 ± 58.9
(67.1)
Motile sperm (%) 51.3 ± 11.9
(53.0)
Morphologically normal sperm (%) 10.7 ± 5.2 
(10.0)
Total motile count (× 106) 139 ± 112
(117)
Total sperm count (× 106) 295 ± 220
(242)
Table 2. Summary statistics for the serum concentrations of men’s reproductive hormones (n = 360) and 
urinary concentrations of BPA (n = 375).
Geometric 
mean
Percentile
Variable 5th 25th 50th 75th 95th
FSH (IU/L) 2.9 1.2 2.0 2.9 4.1 6.5
LH (IU/L) 3.3 1.7 2.6 3.3 4.4 6.2
T (nmol/L) 17.8 9.3 14.0 18.1 23.3 31.7
Inhibin B (pg/mL) 207 105 161 217 269 369
E2 (pmol/L) 79.5 41.0 66.0 83.0 103 132
SHBG (nmol/L) 27.3 12.0 20.3 28.0 37.0 58.0
FAI 65.1 36.1 50.7 66.1 81.8 118
FT 11.6 6.2 9.5 11.8 14.6 19.1
FAI/LH 19.7 8.2 14.1 19.2 28.8 47.0
FT/LH 3.5 1.6 2.5 3.7 4.9 7.1
T/E2 ratio 0.22 0.10 0.17 0.23 0.29 0.50
T/LH ratio 5.4 2.5 3.8 5.5 7.5 10.9
BPA (µg/L)a 1.5 < LOD 0.80 1.7 3.0 6.5
aLOD for BPA was 0.4 µg/L; 89.7% of the urinary concentrations were > LOD.
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with FAI/LH (but not T/LH or FT/LH) and 
FAI after controlling for covariates.
Our results are divergent from those 
reported previously by Takeuchi and Tsutsumi 
(2002) and Hanaoka et al. (2002). Takeuchi 
and Tsutsumi (2002) used an enzyme-linked 
immunosorbent assay (ELISA) to measure 
BPA in the serum of men and women, show-
ing statistically significant posi tive correlations 
between BPA concentrations and total T and 
FT levels in all subjects. However, these dif-
ferences may be related to differences both in 
population size and the different methodo logi-
cal approaches to meas uring BPA (i.e., ELISA 
versus online SPE-HPLC-MS/MS; human 
serum versus urine). ELISA is known to be a 
very sensitive method but is not as specific as 
MS/MS. It is possible that with ELISA, sub-
stances other than BPA and its conjugates—
including other bisphenols—can be detected 
(Vandenberg et al. 2010). Hanaoka et al. 
(2002) examined men occupationally exposed 
to BPA and reported that urinary concen-
trations of BPA, measured by HPLC with 
electro chemical detection, were significantly 
higher in exposed workers than in controls; the 
authors also found a significant inverse asso-
ciation between urinary BPA concentrations 
and serum FSH levels. Nevertheless, FT levels 
(measured by radio immuno solvent assay) did 
not differ between the two groups.
In the present study we did not observe 
any relationship between serum FSH levels 
and urinary BPA concentrations, but we did 
observe an inverse association between FAI 
and urinary BPA concentrations. Hanaoka 
et al. (2002) speculated that BPA binds to 
estrogen receptor (ER) in the pituitary gland, 
resulting in direct suppression of FSH secre-
tion; this is based on studies that have found 
ERs in the pituitary gland (Pelletier 2000) and 
that E2 directly inhibits gonado tropin secre-
tion at the pituitary level in men (Finkelstein 
et al. 1991). Recently, Meeker et al. (2010) 
evaluated men referred for fertility work-up; 
in a subset who collected at least two urine 
samples (n = 75), the authors observed inverse 
associations between urinary BPA and FAI, 
E2, and thyroid-stimulating hormone levels. 
However, when they analyzed the entire 
cohort of men (n = 167), all of whom col-
lected a single urine sample, urinary BPA 
concentrations were inversely associated only 
with serum inhibin B levels and positively 
associated with serum FSH levels.
There is a large and consistent body of 
litera ture showing BPA to be estrogenic 
(Richter et al. 2007; Wetherill et al. 2007), 
and it is considered by some researchers to be 
one of the most potent reproductive toxicants 
among EDCs (Maffini et al. 2006). Animal 
and in vitro studies have shown that BPA is 
associated with the induction of testicular 
toxicity in neonatal, pubertal, and adult 
rodents (Richter et al. 2007; Wetherill et al. 
2007). Akingbemi et al. (2004) described an 
inhibitory effect of BPA on testicular steroido-
genesis at low exposure levels in pubertal 
rats, which they ascribed to an ER-mediated 
effect. In addition to its anti androgenic effects 
through ER-mediated down-regulation of 
steroido genesis (and thereby T production), 
BPA might also act as an androgen receptor 
antagonist, preventing endogenous andro-
gens from regulating androgen-dependent 
transcription (Wetherill et al. 2007). The dis-
ruption of the androgen receptor–androgen 
interaction has been speculated to be sig-
nificant in eliciting adverse effects on the 
Table 4. Correlation coefficients between semen parameters and urinary BPA concentrations (univariate 
analysis) (n = 375).a
BPA concentration (µg/L)
Creatinine-adjusted 
BPA concentration (µg/g)
Variable R (95% CI) p-Value R (95% CI) p-Value
Seminal volume –0.16 (–0.26 to –0.06) < 0.01 –0.11 (–0.21 to –0.01) 0.03
Sperm concentrationb –0.03 (–0.13 to 0.07) 0.57 –0.003 (–0.10 to 0.10) 0.95
Motile sperm (%) –0.004 (–0.11 to 0.10) 0.94 –0.08 (–0.18 to 0.02) 0.11
Morphologically normal sperm (%)b 0.05 (–0.05 to 0.15) 0.33 0.02 (–0.08 to 0.12) 0.72
Total motile countb –0.09 (–0.19 to 0.01) 0.07 –0.08 (–0.18 to 0.02) 0.12
Total sperm countb –0.11 (–0.21 to –0.01) 0.03 –0.07 (–0.17 to 0.03) 0.19
aBPA, sperm concentration, and total motile count were ln‑transformed. bn = 374. 
Table 5. Multivariate analysis for men’s reproduc‑
tive hormones and urinary BPA concentrations 
(n = 302).a 
Urinary BPA  
concentrations
Variable β (95% CI)
FSH 0.04 (–0.04 to 0.12)
LH 0.05 (–0.01 to 0.12)
T 0.01 (–0.04 to 0.06)
Inhibin B –0.01 (–0.07 to 0.04)
E2 0.49 (–3.1 to 4.1)
SHBG 0.07 (0.007 to 0.13)*
FAI –0.05 (–0.09 to –0.004)*
FT –0.01 (–0.06 to 0.03)
FAI/LH –0.11 (–0.18 to –0.03)**
FT/LH –0.07 (–0.13 to 0.001)
T/E2 ratio 0.01 (–0.05 to 0.08)
T/LH ratio –0.04 (–0.11 to 0.03)
BPA, urinary creatinine concentration, and all hormones 
except E2 were ln‑transformed. 
aControlling for age, age squared, BMI, smoking status 
(current smoker vs. not current smoker), ethnicity (African 
American vs. others), study center (Missouri vs. Iowa, 
Minnesota, or California), urinary creatinine concentra‑
tion, and time of sample collection. *p ≤ 0.05. **p ≤ 0.01. 
Table 6. Multivariate analysis for semen param‑
eters in men and urinary BPA concentrations 
(n = 317).
Urinary BPA 
concentration
Variable β (95% CI)
Seminal volumea –0.18 (–0.40 to 0.01)
Sperm concentrationa 0.01 (–0.08 to 0.10)
Motile sperm (%)b –0.38 (–1.66 to 0.90)
Morphologically normal 
sperm (%)c
0.16 (–0.45 to 0.77)
Total motile countd –0.05 (–0.17 to 0.70)
Total sperm counta –0.04 (–0.14 to 0.06)
n = 315 for seminal volume, and n = 314 for sperm 
concentration and total sperm and total motile count. 
BPA, sperm concentration, and total motile count were 
ln‑transformed. 
aControlling for age, age squared, BMI, study center 
(Missouri vs. Iowa, Minnesota, or California), stressful 
life events (< 2 vs. ≥ 2 events), and ejaculation abstinence 
time. bControlling for age, age squared, BMI, study center 
(Missouri vs. Iowa, Minnesota, or California), stressful 
life events (< 2 vs. ≥ 2 events), time from semen collection 
to initial processing, and time required to conduct semen 
analysis. cControlling for age, age squared, BMI, study 
center (Missouri vs. Iowa, Minnesota, or California), and 
stressful life events (< 2 vs. ≥ 2 events). dControlling for 
age, age squared, BMI, study center (Missouri vs. Iowa, 
Minnesota, or California), stressful life events (< 2 vs. ≥ 2 
events), ejaculation abstinence time, time from semen 
collection to initial processing, and time required to con‑
duct semen analysis. 
Table 3. Correlation coefficients for men’s reproductive hormones and urinary BPA concentrations (uni‑
variate analysis) (n = 360).a
BPA concentration (µg/L)
Creatinine-adjusted  
BPA concentration (µg/g)
Variable R (95% CI) p-Value R (95% CI) p-Value
FSH (IU/L) –0.004 (–0.11 to 0.10) 0.95 0.06 (–0.04 to 0 .16) 0.28
LH (IU/L) 0.09 (–0.01 to 0.19) 0.10 0.08 (–0.02 to 0.18) 0.14
T (nmol/L) –0.05 (–0.15 to 0.05) 0.39 –0.05 (–0.15 to 0.05) 0.37
Inhibin B (pg/mL) –0.11 (–0.21 to –0.01) 0.04 –0.06 (–0.04 to 0.16) 0.26
E2 (pmol/L) 0.07 (–0.03 to 0.17) 0.22 0.03 (–0.07 to 0.13) 0.60
SHBG (nmol/L) –0.02 (–0.12 to 0 .08) 0.72 0.05 (–0.05 to 0.15) 0.37
FAI –0.02 (–0.12 to 0.08) 0.67 –0.11 (–0.21 to –0.01) 0.04
FT –0.05 (–0.15 to 0.05) 0.38 –0.09 (–0.19 to 0.01) 0.08
FAI/LH –0.08 (–0.18 to 0.02) 0.14 –0.13 (–0.23 to –0.03) 0.01
FT/LH –0.11 (–0.21 to –0.01) 0.04 –0.13 (–0.23 to –0.03) 0.01
T/E2 ratio –0.09 (–0.19 to 0.01) 0.11 –0.05 (–0.15 to 0.05) 0.36
T/LH ratio –0.11 (–0.21 to –0.01) 0.04 –0.10 (–0.20 to 0.01) 0.05
aBPA and all hormones except for E2 were ln‑transformed.
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male reproductive system, including sexual 
dysfunctions (Li et al. 2010).
Our results suggest that FAI levels—one of 
the markers of the biologically active T—may 
be somewhat decreased by BPA exposure. 
Nonetheless, the magnitude of the effect of 
BPA in the present cross-sectional study on 
FAI was small compared with, for example, 
the diurnal variation in this parameter in 
healthy young men (Bremner et al. 1983; 
Diver et al. 2003). However, the effects of 
long-term exposure to BPA in adult men are 
unknown, and we cannot rule out that such 
exposure may exert an effect on their hormone 
production. It is also important to point out 
that we are certainly exposed to a mixture of 
EDCs, and the cumulative effects that these 
chemicals may exert in combination are only 
now being studied (Kortenkamp 2008).
In the present study, we observed an 
inverse association between BPA exposure and 
FAI levels in vivo with no apparent compen-
satory increase in serum gonadotropins, as 
shown by the lack of significant associations 
with LH and FSH. However, we cannot rule 
out a possible compensatory increase in serum 
gonadotropins in a larger study or another 
kind of study population. The fact that FAI 
and SHBG are statistically associated with uri-
nary BPA concentrations while T individu-
ally is not suggests that the small associations 
observed between these hormones and BPA 
could have resulted from an increase in SHBG. 
The regulation of SHBG is not completely 
understood, but androgen action lowers serum 
SHBG, whereas estrogen action increases it. 
The increase in SHBG levels we report here 
could be a direct result of the estrogenic action 
of BPA. Alternatively, it is possible that BPA 
acts by decreasing androgen action through 
ER-mediated decrease in steroid production. 
However, there might be non causal explana-
tions for the association with SHBG as well.
We speculate that BPA in vivo may act at 
several levels. In addition to the altera tion of 
markers of androgenic action, the endocrine 
feedback loop (mainly the hypothalamic– 
pituitary–target organ axis) could also be 
affected by BPA, showing no compensa-
tory mechanisms of increased LH or FSH. 
Alternatively, because there is no change in T 
with BPA (adjusted β = 0.01; 95% CI, –0.04 
to 0.06), this suggests that the signal is insuffi-
cient to trigger the feedback mechanism to the 
hypothalamus and pituitary.
We observed no significant associations 
between semen parameters and BPA expo-
sures in our population of fertile men. It is 
important to remember that spermato genesis 
takes 70–80 days, and a clear association 
between semen parameters and relatively low 
and chronic urinary BPA concentrations may 
be difficult to assess. It is also possible that in 
men with compromised semen quality (such 
as those attending an infertility clinic) or men 
exposed occupationally to higher concentra-
tions of BPA, some associations may be seen 
that are absent in our fertile population.
Urinary concentrations of BPA in our 
subjects were only about half as high as 
those reported in a national sample of U.S. 
men (CDC 2008). For example, the 25th, 
median, and 75th percentile values for BPA 
in adult males (range, 18–65 years of age) 
from NHANES 2003–2004 were 1.5, 3.1, 
and 6.1 µg/L, respectively, compared with 
0.80, 1.7, and 3.0 µg/L in the present study. 
Whether the lower BPA urinary concentra-
tions in the men in our study compared with 
men in NHANES was related to their fertility 
is not a question we could examine in this data 
set. Recently, in an analysis of NHANES data, 
Stahlhut et al. (2009) showed that BPA was 
detectable in urine up to 24 hr after the last 
meal, suggesting substantial non food expo-
sure, accumulation in body tissues such as fat, 
or both. In addition, we cannot rule out some 
level of occupational exposure to BPA in our 
study population, but it is not likely because 
of the relatively low levels mentioned above.
Our study was limited because we selected 
only fertile men; therefore, our results should 
be applied only to that type of population. 
Also, we used a single urine sample to assess 
BPA exposure and a single serum sample 
to describe hormone function. However, 
Mahalingaiah et al. (2008) maintained that, 
despite within-person variability in urinary 
BPA concentrations, a single sample is pre-
dictive of long-term exposure (over weeks 
to months) and provides good sensitivity to 
classify individuals in epidemiologic stud-
ies. Exposure measurement error is likely in 
the present study; if this measure ment error 
was non differential, we could expect that, on 
average, the effect estimates might be biased 
toward the null. Similarly, a single sample 
can be used to classify men’s reproduc-
tive hormones (Bjornerem et al. 2006). As 
with all studies of semen quality, small par-
ticipation rates, potential selection bias, and 
uncontrolled confounding are of concern. 
In a previous study (Swan et al. 2003), we 
examined selection bias by comparing ques-
tionnaire data on time to pregnancy and his-
tory of infertility, as well as demo graphics, 
of study subjects and nonparticipants and of 
men who did and did not give semen samples. 
Reassuringly, we found little evidence that 
those populations differed.
Conclusions
Our results suggest that low environmental 
levels of BPA in a large group of prospectively 
recruited fertile men is not associated with 
sperm quality but is weakly associated with 
markers of androgenic action. These results 
may reflect the estrogenic effect of BPA, 
which we hypothesize could be related to an 
inhibitory effect on testicular steroido genesis. 
However, associations between BPA expo-
sure and measures of reproductive function 
in fertile men were small and of uncertain 
clinical significance. Consequently, further 
studies will be needed to elucidate the associa-
tions between BPA exposure and reproductive 
function in men.
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